30May 2022
Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation

Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation

Despite its invasive nature, endomyocardial biopsy (EMB) is the standard gold method for surveillance of acute cardiac allograft rejection (ACAR). On 15 occasions (6%), patients who were randomized to the CMR arm underwent EMB for clarification or logistic reasons, representing a 94% reduction in the requirement for EMB-based surveillance. A noninvasive CMR-based surveillance strategy for ACAR in the first year after orthotopic heart transplantation is feasible compared with EMB-based surveillance.

  • #cardiology

Like

Save

Share